Wednesday, March 10, 2010

Pharmaceutical industry CEO salaries

This is being republished from NonClinicalJobs.com 

Last week, you may have caught some news indicating that "Pfizer CEO Gets 12.5 Percent Raise From Last Year's $14.9M." Wow, it's hard to imagine what you could do with that much money.

Is that a base salary of $14.9 million? No, but this is how it breaks down:
CEO Jeff Kindler’s overall compensation for last year was $14.9 million, according to Dow Jones Newswire, a slight decrease from the year before, mostly because of lower stock prices for much of 2009. But Kindler stands to receive more this year: a base salary of $1.8 million (versus $1.6 million last year), an incentive target award of up to $2.7 million (from $2.4 million last year) and a long-term incentive award of $12 million (compared with $8.3 million last year).
Now, let's compare Kindler’s compensation package to a few other CEOs in the pharma industry:
  • Abbott Laboratories’ Miles White reportedly received $25.3 million in 2008
  • Merck & Co.’s Richard T. Clark, reportedly received $17.3 million in 2008
  • Andrew Witty from GlaxoSmithKline received 1.78 million pounds ($2.51 million) in 2008
  • David Brennan from AstraZeneca  received $4.7 million in 2008
You can actually find pharma CEO salaries posted on Forbes.com and other websites.



In 2008, FiercePharma reported the following CEO salary figures:

1. Miles White - Abbott - $33.4M
2. Fred Hassan - Schering-Plough - $30.1M
3. Bill Weldon - Johnson & Johnson - $25.1M
4. Bob Essner - Wyeth - $24.1M
5. Robert Parkinson - Baxter - $17.6M
6. Daniel Vasella - Novartis - $15.5M
7. Richard Clark - Merck - $14.5M
8. Frank Baldino - Cephalon - $13.5M
9. Sidney Taurel - Eli Lilly - $13M
10. Jeff Kindler - Pfizer - $12.6M
11. Jim Cornelius - Bristol-Myers Squibb - $11.3
12. Franz Humer - Roche - $11.1M
13. Robert Coury - Mylan - $8.5M
14. Jean-Pierre Garnier - GlaxoSmithKline - $6M
15. Werner Wenning - Bayer - $4.77M
16. David Brennan - AstraZeneca - $4.3M
17. Gerard Le Fur - Sanofi-Aventis - $3.27M

No comments:

Post a Comment

Blog Widget by LinkWithin